Oct. 16 Quick Takes: Dren Bio’s $60M series A; plus Roche, Synairgen, Astellas-iota and more

By BioCentury Staff

Oct 17, 2020 | 2:42 AM GMT

Dren Bio raises $60M series A to develop cell-depleting engineered proteins
Dren Bio raised a